A robust
and diverse data engine
Our proprietary GENIISYS™ platform consists of a large and fast-growing bio- and data-repository of deeply-phenotyped consented research participants. The diverse dataset has the potential to power understanding across multiple disease areas of interest including cancers, neurodegenerative diseases, sickle cell, autoimmune and rare diseases, and infectious diseases.